Nordic-Neurostim ApS: Financial statements 2019
CVR: 38049909
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Nordic-Neurostim ApS (CVR 38049909) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 33,278 and a net result of DKK -15,724 compared with DKK 184,201 the year before. That is a decrease of 86.6% compared with the year before. Equity in the 2019 report amounted to DKK 116,643. The solvency ratio was 3.8%.
- Gross Profit
- DKK 33,278
- Profit/Loss
- DKK -15,724
- Equity
- DKK 116,643
- Total Assets
- DKK 3,032,328
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Nordic-Neurostim ApS has published its annual report for 2018. Gross profit came to DKK 248,597, and the net result was DKK 184,201.
About Nordic-Neurostim ApS
Nordic-Neurostim ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christian Peter Christiansen. The board consists of Morten Kristian Haugland (chair) and Christian Peter Christiansen. The company is owned by MORTEN HAUGLAND HOLDING ApS, Varebex ApS and Medodan Consulting ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 89,658 and a net result of DKK -33,430 compared with DKK -10,264 the year before. Equity in the 2025 report amounted to DKK -1,858,514.
